Lilly Launches Gain Early Momentum To Kick Off Return To Growth Year
This article was originally published in The Pink Sheet Daily
Executive Summary
The GLP-1 agonist Trulicity and the cancer drug Cyramza are among the new drugs that Lilly expects will drive long-term growth.